PUMA BIOTECHNOLOGY, INC.: accounts_payable
| Value | {"amount": 87000, "concept": "us-gaap:AccountsPayableCurrent", "currency": "USD"} |
|---|---|
| Period | (as of 2011-12-31) |
| Status | current |
| Entity | PUMA BIOTECHNOLOGY, INC. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T13:37:32.067047+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/30d39b87-a6d5-4310-b0ef-874d1e985d0b
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001193125-13-136650Retrieved: 2026-08-19T13:37:32.067047+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001401667/accounts-payable/2011-12-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/30d39b87-a6d5-4310-b0ef-874d1e985d0b
History
- supersedes {"amount": 86669, "concept": "us-gaap:AccountsPayableCurrent", "currency": "USD"} (evidence 0001193125-12-139883)